University of Cincinnati: Sarcoidosis trials

The registry lists 14 Sarcoidosis studies with University of Cincinnati as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 4Phase 3 3Phase 4 6No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Patient Reported Outcome Instruments in SarcoidosisStatus unknownNCT04342403
• Registry for Advanced SarcodiosisStatus unknownNCT03769987
• Pirfenidone for Progressive Fibrotic SarcoidosisStatus unknownNCT03260556Phase 4
• Riociguat for Sarcoidosis Associated Pulmonary HypertensionStatus unknownNCT02625558Phase 4
• Use of Immunosuppressive Therapy for SarcoidosisStatus unknownNCT02356445
• Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)Status unknownNCT02188017Phase 4
• Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)Status unknownNCT01830959Phase 4
• Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)Status unknownNCT01467791
• Rituximab for Pulmonary SarcoidosisCompletedNCT00855205Phase 2
• The Efficacy and Safety of CC-10004 in Chronic Cutaneous SarcoidosisCompletedNCT00794274Phase 2/3
• Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary HypertensionCompletedNCT00581607Phase 2/3
• Use of Armodafinil for Fatigue in SarcoidosisCompletedNCT00555347Phase 2/3
• Inhaled Iloprost for Sarcoidosis-associated Pulmonary HypertensionCompletedNCT00403650Phase 4
• Use of Focalin for Fatigue in SarcoidosisCompletedNCT00361387Phase 4